ATRI (Atrion Corp) Market Value to Book Value Ratio

Atrion Corp (ATRI) - corporate logo

The price-to-book ratio for Atrion Corporation (ATRI) on the GURU.Markets chart confirms the company's leadership in the high-precision fluid delivery systems segment for oncology. The daily price action via 3.37 shows the current value of the metric, reinforcing the stability of its own US plants and full control over production cycles. The humanitarian status of biomedicine minimizes geopolitical risks, guaranteeing business resilience under any conditions.

ATRI - Atrion Corporation Inc. Market-to-Book Ratio over the range 07/04/2022 - 08/31/2024
Manufactured products of Atrion Corp.

Amidst fierce patent battles within the medtech niche, Atrion Corporation (ATRI) must effectively capitalize on its assets. This indicator compares the current market value of the business with its net assets, identifying whether capital is overvalued or undervalued. By analyzing changes in the market-to-book ratio, an investor can discern the market premium relative to the company's tangible assets. The stability of this ratio confirms a fair business valuation, allowing for the timely identification of an entry point while eliminating the risk of missed opportunities.

Direct competitors

Intuitive Surgical - Market Capitalization to Book Value Ratio|DHR (danaher.com) - Market Capitalization to Book Value|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio ANGO (AngioDynamics, Inc.)|CERS: Market Capitalization to Book Value|Market Value to Book Value Ratio Teknova|MGRM (Monogram Technologies Inc.) - Capitalization to Book Value Ratio|STSS: Market Value to Book Value Ratio|Market Capitalization to Book Value InfuSystem Inc (INFU)|Market Cap to Net Assets Ratio Utah Medical Products|Market Cap to Book Value Multiple KRMD (korumedical.com)|Market Value to Book Value Ratio Nyxoah|MBOT - Market Value to Book Value|Pro-Dex Corp - Market Cap to Net Assets Ratio|ZTEK: Market Capitalization to Book Value Ratio|ELUT (Elutia Inc.) - Market Value to Book Value Ratio|milestonescientific.com (MLSS) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio NXGL (NEXGEL)|Market-to-Book Ratio RVP|Market Value to Book Value Ratio Harvard Bioscience HBIO|Capitalization to Book Value Ratio Femasys Corporation FEMY|Market Cap to Net Assets Ratio Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Market Cap to Book Value Multiple|Market Value to Book Value Ratio CJMB (Callan JMB Corp)|NURO - Market Capitalization to Book Value